Effective Management of IgA Nephropathy: Integrating New Therapies and Clinical Insights

As novel mechanisms of action that target key mechanistic pathways are under investigation to address current unmet needs in IgAN, clinicians need expert guidance on the rationale for new agents and how they fit into the treatment landscape of IgAN, including patient selection strategies, particularly as treatment options for IgAN expand. Such education may better prepare clinicians to use these newly approved therapies to help improve patient outcomes.

In this course, we will learn about new systemic therapies for the treatment of IgA Nephropathy and considerations for treatment with various mechanisms and novel classes of treatment as well as strategies for maximizing patient adherence. You will interact with the 5-part Q&A module where you can participate by voting in polls, reading expert answers, leaving comments, and asking follow-up questions. All references and citations linked to the original sources will also be accessible.
 
Educational Partner: theMednet

Commercial Support: Supported by an educational grant from Otsuka America Pharmaceutical, Inc.

Target Audience

This activity is created for nephrologists who care for patients diagnosed with IgA nephropathy.

Learning Objectives

Upon completion of this activity, learners will be able to:

  • Review the rationale for targeting key mechanistic pathways in the treatment of IgAN;
  • Describe the clinical significance of recent evidence supporting the use of novel targeted agents and their impact on the treatment landscape of IgAN;
  • Outline practical strategies to optimize clinical protocols regarding the current treatment of IgAN with novel targeted agents.
Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
For more information, please contact:
CME Coordinator Contact Name: 
ACHL
CME Coordinator Contact Phone: 
877-444-8435 ext. 160

You may also be interested in

39th Stocker's Aspen Conference on Pediatric Disease
K Bar S Lodge | Keystone, SD
 
This activity is designed to advance the knowledge of surgical and pediatric pathologists on a wide range of neoplastic and non-neoplastic diseases encountered in pediatric pathology.
3rd Annual University of Chicago Neurotrauma Symposium: Penetrating Brain Injury – Exploring Practice Changes, Persistent Gaps, and Advancing Research Collaborations
David Rubenstein Forum | Chicago, IL
 
Through discussions on clinical priorities, research methodologies, and interdisciplinary collaborations, this activity will drive innovation and advance trauma management practices.
John F. Gilmore Symposium on Nutrition and Small Bowel Disorders
Gleacher Center | Chicago, IL
 
The goal of the John F. Gilmore Symposium on Nutrition and Small Bowel Disorders is to introduce healthcare professionals to the field of nutrition support and increase awareness of the role of diet in disease management.
Summary
Activity opens: 
02/15/2025
Activity expires: 
02/15/2026
FACULTY
Adrian P. Abreo, MD
 
Pietro A. Canetta, MD
 
Tripti Singh, MBBS


Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and theMednet. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
 
The University Of Chicago Pritzker School Of Medicine designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Registration: View this activity by visiting ACHL's website.
If you are logged in, you can click on the "Complete Activity" button below!
 
Please login or create an account to proceed.